SCIENTIFIC EVIDENCE
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma
EMBO molecular medicine
Xu D, Gao Y, Liu S, Yin S, Hu T, Deng H, Zhang T, Hegedüs B, Marti TM, Dorn P, Liang SQ, Schmid RA, Peng RW, Shu Y.
